Inventor · disambiguated record
Brad Newhouse
Also filed as: NEWHOUSE BRAD
18 granted patents·6 pending applications·81 citations·filing 2006–2024
93Inventor score
Files withARRAY BIOPHARMA INC9MIRATI THERAPEUTICS INC7AHRENDT KATERI A2VENTIRX PHARMACEUTICALS INC2BOYS MARK LAURENCE1
Top patents by PatentIndex Score
24 records- 0196US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0292US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 0391US10647715B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2019·Granted May 12, 2020·10 cites·9 claims
- 0490US7491829B2RAF inhibitor compounds and methodsARRAY BIOPHARMA INC·Filed 2006·Granted Feb 17, 2009·17 cites·49 claims
- 0585US9763942B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Sep 19, 2017·5 cites·18 claims
- 0684US8691809B2Substituted benzoazepines as toll-like receptor modulatorsHOWBERT JAMES JEFFRY·Filed 2010·Granted Apr 8, 2014·8 cites·17 claims
- 0782US10154995B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 18, 2018·3 cites·18 claims
- 0881US9670208B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 6, 2017·4 cites·19 claims
- 0977US9655904B2Substituted benzoazepines as toll-like receptor modulatorsVENTIRX PHARMACEUTICALS INC·Filed 2015·Granted May 23, 2017·2 cites·8 claims
- 1077US9126940B2Substituted benzoazepines as toll-like receptor modulatorsVENTIRX PHARMACEUTICALS INC·Filed 2014·Granted Sep 8, 2015·3 cites·15 claims
- 1177US8394795B2Pyrazole [3, 4-B] pyridine Raf inhibitorsAHRENDT KATERI A·Filed 2009·Granted Mar 12, 2013·5 cites·45 claims
- 1277US2024309020A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1376US8338452B2Raf inhibitor compounds and methods of use thereofAHRENDT KATERI A·Filed 2009·Granted Dec 25, 2012·4 cites·49 claims
- 1475US11247990B1Bicyclic fused pyridine compounds as inhibitors of TAM kinasesARRAY BIOPHARMA INC·Filed 2018·Granted Feb 15, 2022·1 cites·20 claims
- 1575US9174981B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsBOYS MARK LAURENCE·Filed 2011·Granted Nov 3, 2015·3 cites·30 claims
- 1672US9809590B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Nov 7, 2017·1 cites·29 claims
- 1768US2020262837A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1867US10669269B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 1959US2020308170A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2057US2009176809A1Raf inhibitor compounds and methodsLAIRD ELLEN·Filed 2008·Application pending·0 cites
- 2153US9969694B2N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted May 15, 2018·0 cites·1 claims
- 2253US2023279025A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2343US7566716B2Imidazopyrazines as Raf inhibitor compoundsARRAY BIOPHARMA INC·Filed 2006·Granted Jul 28, 2009·0 cites·21 claims
- 2435US2012157448A1Compounds for treating neurodegenerative diseasesCOOK ADAM·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brad Newhouse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →